EPB41L4A and renal carcinoma: Importantly, the overexpressed lncRNA EPB41L4A-DT in the renal cancer cell line 786-O, cell proliferation assays, flow cytometry, and clonogenic assay showed that upregulating EPB41L4A-DT may inhibit the proliferation of renal cancer cells (Xu et al., 2016).